Close

Form 8-K CROSS COUNTRY HEALTHCARE For: May 17

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 4/24/2024

1. TSLA
2. ENPH
3. TXN
4. SPOT
5. V
6. BA
7. KMB
8. MSFT
9. GM
10. FI


May 18, 2022 3:01 PM EDT

UNITED STATES 
 SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.  20549
 
 
 
FORM 8-K
 
 
 
CURRENT REPORT


Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934


Date of Report (Date of earliest event reported) May 17, 2022
 graphic
 
 
 
Cross Country Healthcare, Inc.
(Exact name of registrant as specified in its charter)
 
 

Delaware
0-33169
13-4066229
(State or Other Jurisdiction
of Incorporation)
(Commission
File Number)
(I.R.S. Employer
Identification No.)
 
6551 Park of Commerce Boulevard, N.W., Boca Raton, Florida 33487
(Address of Principal Executive Office) (Zip Code)

(561) 998-2232
(Registrant’s telephone number, including area code)

Not Applicable
(Former name or former address, if changed since last report)
 
Securities registered pursuant to Section 12(b) of the Act:
 
Title of each class Trading Symbol Name of each exchange on which registered
Common stock, par value $0.0001 per share
 CCRN
 The Nasdaq Stock Market LLC

 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
☐            Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐            Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐            Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐            Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2).
Emerging growth company ☐
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 5.07.
Submission of Matters to a Vote of Security Holders


(a)
On May 17, 2022, the Company held its Annual Meeting of Stockholders (“Annual Meeting”).

(b)
The following items of business were voted upon by stockholders at the Annual Meeting:

(i) A proposal to elect the directors listed below for a one-year term ending in 2023 or until their successors are duly elected and qualified was approved with the following vote:
 Director
  
For
    
Against
    
Abstentions
    
Broker
Non-Votes
  
Kevin C. Clark
    
29,136,536
      
   647,511
      
11,029
      
3,066,348
  
W. Larry Cash
    
29,080,417
      
   703,625
      
11,034
      
3,066,348
  
Thomas C. Dircks
    
28,683,761
      
1.100,270
      
11,045
      
3,066,348
  
Gale Fitzgerald
    
28,586,343
      
1,197,812
      
10,921
      
3,066,348
  
Darrell S. Freeman, Sr.
    
29,634,784
      
   146,257
      
14,035
      
3,066,348
  
John A. Martins
    
29,477,204
      
   306,828
      
11,044
      
3,066,348
  
Dr. Janice E. Nevin, MD, MPH
    
28,994,071
      
   789,899
      
11,106
      
3,066,348
  
Mark Perlberg, JD
    
28,979,521
      
   804,530
      
11,025
      
3,066,348
  


(ii) The ratification of the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2022 was approved as follows:

 
For
 
 
Against
  
Abstentions
    
Broker Non-Votes
 
32,817,093
  
37,269
  
   7,062
    
0


(iii) The compensation of named executive officers was approved, on an advisory (non-binding) basis, by the votes set forth below:

 
For
 
 
Against
  
Abstentions
    
Broker Non-Votes
 
28,583,660
  
731,409
  
480,007
    
3,066,348

 
Item 9.01
Financial Statements and Exhibits

(d) Exhibits

          
Exhibit
Description
     
  104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURE
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.
 

 
 
CROSS COUNTRY HEALTHCARE, INC.
 
 
 
 
 
 
 
 
Dated:
May 18, 2022
By:
/s/ William J. Burns
  
 
 
 
William J. Burns
 
 
 
Executive Vice President & Chief Financial Officer




Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

SEC Filings